Libertas 7 Overview
- Year Founded
-
1946

- Status
-
Public
- Employees
-
52

- Stock Symbol
-
LIB

- Investments
-
3
- Share Price
-
$1.78
- (As of Tuesday Closing)
Libertas 7 General Information
Description
Libertas 7 SA is engaged in the real estate industry. It is structured in two main areas of business: investment and real estate. The company's investment activity includes Medium/long term investments; Investment in equities and others.
Contact Information
Website
www.libertas7.esCorporate Office
- Calle Caballeros
- Number 36
- 46001 Valencia
- Spain
Corporate Office
- Calle Caballeros
- Number 36
- 46001 Valencia
- Spain
Libertas 7 Stock Performance
As of 18-Feb-2025, Libertas 7’s stock price is $1.78. Its current market cap is $37.7M with 21.1M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.78 | $1.78 | $1.35 - $2.08 | $37.7M | 21.1M | 9.8K | $0.05 |
Libertas 7 Financials Summary
As of 30-Jun-2024, Libertas 7 has a trailing 12-month revenue of $6.92M.
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 11,194 | 11,282 | ||
Revenue | 6,921 | 14,499 | 12,105 | 19,882 |
EBITDA | 3,569 | 5,221 | 3,235 | 3,010 |
Net Income | 1,000 | 2,496 | 1,575 | 1,435 |
Total Assets | 164,439 | 163,845 | 158,703 | 172,331 |
Total Debt | 37,973 | 38,241 | 41,931 | 47,789 |
Libertas 7 Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Libertas 7 Signals
Libertas 7 Investments & Acquisitions (3)
Libertas 7’s most recent deal was a Corporate with Buenavista Equity Partners. The deal was made on 10-Sep-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Buenavista Equity Partners | 10-Sep-2024 | Corporate | Private Equity | ||
Valentia Biopharma | 26-Jun-2008 | Early Stage VC | Biotechnology | ||
Playa de Alboraya | 01-Jan-2006 | Merger/Acquisition | Real Estate Services (B2C) |
Libertas 7 Exits (1)
Libertas 7’s most recent exit was on 26-Jun-2008 from Valentia Biopharma. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Valentia Biopharma | 26-Jun-2008 | Completed |
|
Libertas 7 FAQs
-
When was Libertas 7 founded?
Libertas 7 was founded in 1946.
-
Where is Libertas 7 headquartered?
Libertas 7 is headquartered in Valencia, Spain.
-
What is the size of Libertas 7?
Libertas 7 has 52 total employees.
-
What industry is Libertas 7 in?
Libertas 7’s primary industry is Holding Companies.
-
Is Libertas 7 a private or public company?
Libertas 7 is a Public company.
-
What is Libertas 7’s stock symbol?
The ticker symbol for Libertas 7 is LIB.
-
What is the current stock price of Libertas 7?
As of 18-Feb-2025 the stock price of Libertas 7 is $1.78.
-
What is the current market cap of Libertas 7?
The current market capitalization of Libertas 7 is $37.7M.
-
What is Libertas 7’s current revenue?
The trailing twelve month revenue for Libertas 7 is $6.92M.
-
What is Libertas 7’s annual earnings per share (EPS)?
Libertas 7’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »